Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 32,823 followers.

Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia https://t.co/O0fSQ6nQFX

07 Feb 2023

Reply Repost Favourite

Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia https://t.co/CLOe69t1bb https://t.co/bJ1Wv08GGO

12 Jan 2023

Reply Repost Favourite

New research: Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia: Philadelphia (Ph)-like acute lymphoblastic leukemia (ALL)… https://t.co/wvUvcAD

10 Jan 2023

Reply Repost Favourite

RT @gedefo_sefh: Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philade…

10 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.